Developments in the prescription drug market :  oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016. 

 - 1 online resource (iii, 213 pages) :  illustrations 
<br/><br/> Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.  "Serial no. 114-132."  CRDP Program record. 
<br/><br/>Includes bibliographical references. 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Prescription pricing--United States.<br/>Pharmaceutical industry--Corrupt practices--United States.<br/>Generic drugs--Government policy--United States.<br/>Drug approval--United States.
<br/><br/><label>Index Terms--Genre/Form: </label><br/>Legislative hearings.
<br/><br/><label>LC Class. No.: </label>KF27  / .O94 2016 
<br/><br/><label>GPO Item No.: </label>1016-C (MF) 
<br/><br/><label>Gov. Doc. Class. No.: </label>Y 4.G 74/7:114-132 
<br/><br/><label>Report. No.: </label>Serial no. 114-132 (United States. Congress. House. Committee on Oversight and Government Reform)